Form D · Other Health Care

TRANSENTERIX INC

Morrisville, NC · CIK 0001423503

Offering snapshot reported Aug 9, 2013 · SEC filing

Reported sold
$2M
Offering amount: $2.5M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 5, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 9, 2013Initial$1,998,002No comparison9SEC filing
Feb 9, 2012Amendment$15,179,413$289,255vs Dec 14, 201115SEC filing
Dec 14, 2011Initial$14,890,158No comparison9SEC filing
Oct 15, 2009Initial$40,150,000No comparison10SEC filing
Jan 9, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-201136

Source: Form D, filed Aug 9, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dennis Dougherty Director
Aftab Kherani Director
Garheng Kong Director
Paul La Violette Director
Fred Mc Coy Director
David Milne Director
John Onopchenko Director
Todd M. Pope Director, Executive
Matt Rieke Director
Andrew Schiff Director
William N. Starling Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
635 Davis Drive Suite 300
Morrisville, NC, 27713